Log in
NASDAQ:ALNY

Alnylam Pharmaceuticals Earnings Date, Estimates & History

$123.32
-1.56 (-1.25 %)
(As of 10/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$121.56
Now: $123.32
$125.38
50-Day Range
$121.19
MA: $136.50
$147.00
52-Week Range
$83.06
Now: $123.32
$167.33
Volume536,029 shs
Average Volume695,944 shs
Market Capitalization$14.30 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.5

Earnings

Alnylam Pharmaceuticals (NASDAQ:ALNY) Earnings Information

Alnylam Pharmaceuticals last issued its earnings data on August 6th, 2020. The biopharmaceutical company reported ($1.56) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.82) by $0.26. The business had revenue of $77.50 million for the quarter, compared to analysts' expectations of $98.76 million. Its revenue for the quarter was up 102.9% compared to the same quarter last year. Alnylam Pharmaceuticals has generated ($8.11) earnings per share over the last year. Alnylam Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, November 5th, 2020. Alnylam Pharmaceuticals will be holding an earnings conference call on Thursday, November 5th. Interested parties can register for or listen to the call using this link.

Alnylam Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Alnylam Pharmaceuticals (NASDAQ:ALNY) Earnings Estimates

2020 EPS Consensus Estimate: ($6.14)
2021 EPS Consensus Estimate: ($5.54)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($1.85)($1.79)($1.83)
Q2 20204($1.99)$2.73($0.74)
Q3 20204($1.96)($1.64)($1.86)
Q4 20205($2.08)($1.46)($1.71)
Q1 20213($1.83)($1.44)($1.59)
Q2 20213($1.81)($1.34)($1.50)
Q3 20213($1.73)($1.18)($1.40)
Q4 20212($1.73)($0.34)($1.04)

Alnylam Pharmaceuticals (NASDAQ ALNY) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/5/2020
(Confirmed)
 ($1.75)    Register (Before Market Opens)
8/6/20206/30/2020($1.82)($1.56)($1.56)$98.76 million$77.50 millionTranscript
5/6/20203/31/2020($1.89)($1.62)($1.62)$90.45 million$71.94 millionTranscript
2/6/2020Q4 2019($2.25)($2.47)($2.47)$71.45 million$71.70 millionTranscript
10/31/2019Q3 19($2.17)($1.92)($1.92)$57.14 million$70.06 millionTranscript
8/6/2019Q2 2019($2.06)($2.02)($2.02)$42.24 million$38.20 millionListen
5/1/20193/31/2019($2.20)($1.73)($1.73)$21.60 million$33.29 millionN/A
2/7/201912/31/2018($2.27)($2.09)($2.09)$18.03 million$21.00 millionListen
11/7/20189/30/2018($2.02)($2.43)($2.43)$22.66 million$2.07 millionListen
8/2/2018Q2 2018($1.74)($1.63)($2.03)$16.96 million$29.91 millionN/A
5/3/2018Q1 2018($1.47)($1.41)($1.41)$35.23 million$21.90 millionN/A
2/8/2018Q4 2017($1.38)($1.48)($1.48)$19.31 million$37.90 millionTranscript
11/7/2017Q3 2017($1.23)($1.34)($1.34)$28.15 million$17.10 millionN/A
8/9/2017Q2 2017($1.22)($1.34)($1.34)$23.86 million$15.93 millionListen
5/5/2017Q1 2017($1.22)($1.25)($1.25)$22.91 million$19.00 millionN/A
2/8/2017Q416($1.34)($1.32)($1.32)$10.66 million$17.50 millionListen
11/2/2016Q316($1.14)($1.21)($1.21)$9.14 million$13.70 millionN/A
8/4/2016Q216($1.24)($1.05)($1.05)$8.09 million$8.70 millionListen
5/2/2016Q116($1.05)($1.21)($1.21)$7.79 million$7.30 millionListen
2/11/2016Q415($0.96)($1.07)($1.07)$9.59 million$7.60 millionListen
11/9/2015Q315($0.91)($0.91)($0.91)$7.55 million$6.30 millionN/A
8/6/2015Q215($0.75)($0.85)($0.85)$12.64 million$8.69 millionN/A
5/7/2015Q115($0.65)($0.62)($0.62)$15.40 million$18.51 millionN/A
2/12/2015Q414($0.66)($0.28)($0.28)$13.10 million$24.00 millionN/A
11/5/2014Q314($0.63)($0.58)($0.58)$8.93 million$11.00 millionN/A
8/7/2014Q214($0.54)($0.63)($0.68)$9.36 million$7.30 millionN/A
5/8/2014Q114($1.18)($0.39)$2.92$10.80 million$8.30 millionN/A
2/13/2014Q4 2013($0.48)($0.51)($0.51)$9.98 million$10.80 millionN/A
11/6/2013Q3 2013($0.38)($0.48)($0.48)$8.64 million$9.00 millionTranscript
8/8/2013Q2 2013($0.34)($0.29)($0.29)$8.99 million$8.70 millionListen
5/6/2013Q1 2013($0.31)($0.15)($0.15)$15.56 million$18.60 millionListen
2/7/2013Q4 2012($1.45)($1.20)$15.82 million$8.50 millionListen
11/5/2012Q312($0.32)($0.31)$17.30 million$16.80 millionN/A
8/6/2012($0.21)($0.25)N/A
5/3/2012($0.35)($0.25)N/A
2/9/2012($0.33)($0.33)Transcript
11/1/2011($0.35)($0.31)N/A
8/1/2011($0.36)($0.33)N/A
5/2/2011($0.30)($0.38)N/A
2/17/2011($0.35)($0.16)Transcript
11/3/2010Q3 2010($0.39)($0.23)($0.23)N/A
8/4/2010Q2 2010($0.30)($0.35)($0.35)N/A
5/5/2010Q1 2010($0.30)($0.29)($0.29)N/A
2/25/2010Q4 2009($0.30)($0.19)($0.19)N/A
11/4/2009Q3 2009($0.24)($0.22)($0.22)N/A
8/6/2009Q2 2009($0.29)($0.55)($0.55)N/A
5/7/2009Q1 2009($0.24)($0.19)($0.19)N/A
2/24/2009Q4 2008($0.15)($0.23)($0.23)N/A
11/5/2008Q3 2008($0.21)($0.07)($0.07)N/A
8/6/2008Q2 2008($0.09)($0.31)($0.31)N/A
5/8/2008Q1 2008($0.14)($0.03)($0.03)N/A
2/7/2008Q4 2007($0.22)$0.04$0.04N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.